Related Experiment Video
Updated: Sep 8, 2025

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
Published on: March 30, 2015
Evaluation of renal masses with CEST MRI: Protocol optimization and preliminary results
Xiaojing Wang1, Jochen Keupp2, Ivan E Dimitrov3,4
1Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Chemical Exchange Saturation Transfer (CEST) MRI shows promise for non-invasively characterizing renal masses. This technique can differentiate clear cell renal cell carcinoma (ccRCC) from healthy kidney tissue.
Area of Science:
- Magnetic Resonance Imaging
- Biomedical Engineering
- Oncology
Background:
- Renal mass characterization is crucial for diagnosis and treatment planning.
- Current imaging techniques have limitations in differentiating benign from malignant renal masses.
- Chemical Exchange Saturation Transfer (CEST) MRI is an emerging technique with potential for tissue characterization.
Purpose of the Study:
- To develop and evaluate a CEST MRI protocol for human kidney imaging.
- To assess the feasibility of using CEST MRI for characterizing clear cell renal cell carcinoma (ccRCC).
- To investigate the diagnostic potential of CEST MRI in distinguishing ccRCC from healthy renal tissue.
Main Methods:
- CEST MRI scans were performed at 3 Tesla on 10 healthy volunteers and 5 patients with ccRCC.
- Magnetization Transfer Ratio Asymmetry (MTRasym) values were compared between ccRCC tumors and healthy kidney cortex across different frequency offsets.
- Correlation between CEST parameters and tumor characteristics (volume, necrosis, grade) was analyzed.
Main Results:
- Significant differences in MTRasym values were observed between ccRCC tumors and healthy kidney cortex (p < 0.05).
- No significant differences in MTRasym values were found in the contralateral kidney cortex of RCC patients compared to healthy controls (p > 0.7).
- CEST MRI shows potential for differentiating ccRCC from normal kidney parenchyma.
Conclusions:
- CEST MRI is a promising non-invasive imaging tool for renal mass characterization.
- The developed protocol enables differentiation of ccRCC from healthy kidney tissue.
- Further research is warranted to explore the full clinical utility of CEST MRI in nephro-oncology.
Related Concept Videos
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Imaging Studies III: Computed Tomography
Magnetic Resonance Imaging
Imaging Studies VII: Vascular Imaging

